iTeos Therapeutics Inc.
(ITOS)
undefined
undefined%
At close: undefined
7.68
0.13%
After-hours Dec 13, 2024, 04:15 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | 12.60M | 267.63M | 344.77M | - | - | - |
Cost of Revenue | 898.00K | 813.00K | 615.00K | 535.00K | 611.00K | 505.00K |
Gross Profit | 11.70M | 266.82M | 344.16M | -535.00K | -611.00K | -505.00K |
Operating Income | -151.10M | 126.32M | 244.90M | -45.24M | -28.05M | -21.50M |
Interest Income | 31.77M | 11.36M | 78.00K | - | - | - |
Pretax Income | -109.03M | 148.74M | 256.46M | -38.09M | -22.34M | -18.05M |
Net Income | -112.64M | 96.65M | 214.52M | -38.03M | -22.45M | -18.06M |
Selling & General & Admin | 50.40M | 43.95M | 40.51M | 15.34M | 8.84M | 4.31M |
Research & Development | 113.30M | 97.36M | 59.37M | 29.90M | 19.21M | 17.19M |
Other Expenses | - | -3.26M | -10.18M | -5.93M | -4.78M | -163.00K |
Operating Expenses | 163.70M | 138.04M | 89.69M | 39.31M | 23.27M | 17.82M |
Interest Expense | - | - | - | - | - | 66.00K |
Selling & Marketing Expenses | - | - | - | - | - | - |
Cost & Expenses | 163.70M | 138.04M | 89.69M | 39.31M | 23.27M | 17.82M |
Income Tax | 3.61M | 52.08M | 41.94M | -57.00K | 119.00K | 11.00K |
Shares Outstanding (Basic) | 35.76M | 35.55M | 35.18M | 35.04M | 35.02M | 7.51M |
Shares Outstanding (Diluted) | 35.76M | 37.77M | 37.77M | 35.04M | 35.02M | 7.51M |
EPS (Basic) | -3.15 | 2.72 | 6.10 | -1.09 | -0.64 | -2.4 |
EPS (Diluted) | -3.15 | 2.56 | 5.68 | -1.09 | -0.64 | -2.4 |
EBITDA | -151.10M | 148.38M | 257.08M | -37.84M | -21.72M | -17.48M |
Depreciation & Amortization | 898.00K | 813.00K | 615.00K | 535.00K | 611.00K | 505.00K |